GlassScriptPhysician profile
Linda Abriel
NPI 1770559627
$5,472.64
in general payments reported to CMS, 2019-2025
34 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $545 · 2022: $1,151 · 2023: $1,018 · 2024: $1,277 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,765 · Education: $11.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,764.98 |
| Education | $11.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $675.45 | 2023-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $560.98 | 2021-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $454.36 | 2021-2025 | Botox, Lupron Depot |
| Sumitomo Pharma America, INC. | $434.01 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $398.97 | 2022-2024 | Jelmyto |
| 180 Medical, INC. | $395.15 | 2021-2025 | Gentlecath, Gentlecath Glide |
| Coloplast Corp | $381.68 | 2023-2025 | Speedicath |
| Merck Sharp & Dohme LLC | $280.57 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Urovant Sciences INC | $261.95 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $228.95 | 2021-2024 | Myrisk, Prolaris |
| Boston Scientific Corporation | $201.45 | 2022-2025 | Ams 700, Rezum Generator, Ams 700 Cxr Rte Kit |
| Ferring Pharmaceuticals INC. | $160.55 | 2024-2025 | Adstiladrin |
| Antares Pharma, INC. | $157.94 | 2021-2022 | |
| Tolmar, INC. | $139.31 | 2023-2025 | Eligard, Jatenzo |
| Endo Pharmaceuticals INC. | $124.72 | 2021-2024 | Aveed, Xiaflex |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $98.10 | 2022-2024 | |
| Endo USA, INC. | $89.80 | 2024-2025 | Aveed, Xiaflex, Edex |
| Hollister Incorporated | $55.13 | 2022-2023 | Vapro Pocket |
| Alnylam Pharmaceuticals INC. | $53.65 | 2023-2025 | Givlaari |
| Olympus America INC. | $36.99 | 2024-2025 | Itind System |
| Axonics, INC. | $36.35 | 2023-2024 | Axonics, Bulkamid |
| Angiodynamics, INC. | $32.35 | 2022 | |
| Tempus Ai, INC | $31.59 | 2025 | Xt Cdx |
| Convatec INC. | $26.86 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $20.08 | 2023 | Seglentis |
| Myovant Sciences INC. | $18.39 | 2021 | |
| Abc Home Medical Supply, INC. | $15.95 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.94 | 2023 | Lynparza |
| Allergan, INC. | $15.57 | 2021 | |
| Accord Healthcare, INC. | $15.18 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $15.06 | 2022 | |
| Rochester Medical Corporation | $14.78 | 2022 | |
| Monaghan Medical Corporation | $13.48 | 2023 | Aerochamber |
| Travere Therapeutics, INC. | $11.35 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Abriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.